311 related articles for article (PubMed ID: 28266705)
1. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.
Sasaki K; Margonis GA; Andreatos N; Wilson A; Weiss M; Wolfgang C; Sergentanis TN; Polychronidis G; He J; Pawlik TM
Br J Surg; 2017 Jun; 104(7):926-935. PubMed ID: 28266705
[TBL] [Abstract][Full Text] [Related]
2. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases.
Xu D; Wang HW; Yan XL; Li J; Wang K; Xing BC
Eur J Surg Oncol; 2019 Sep; 45(9):1551-1558. PubMed ID: 30879931
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
4. Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.
Laurent C; Adam JP; Denost Q; Smith D; Saric J; Chiche L
World J Surg; 2016 May; 40(5):1191-9. PubMed ID: 26757718
[TBL] [Abstract][Full Text] [Related]
5. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
[TBL] [Abstract][Full Text] [Related]
6. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
[TBL] [Abstract][Full Text] [Related]
8. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A
Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of R1 resection margin in synchronous and simultaneous colorectal liver metastasis resection: a retrospective cohort study.
Kim NR; Alhothaifi ED; Han DH; Choi JS; Choi GH
World J Surg Oncol; 2023 Jun; 21(1):169. PubMed ID: 37280633
[TBL] [Abstract][Full Text] [Related]
10. Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases.
Pietrantonio F; Mazzaferro V; Miceli R; Cotsoglou C; Melotti F; Fanetti G; Perrone F; Biondani P; Muscarà C; Di Bartolomeo M; Coppa J; Maggi C; Milione M; Tamborini E; de Braud F
Med Oncol; 2015 Jul; 32(7):182. PubMed ID: 26003673
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Impact of Determining Resection Margin Status for Multiple Colorectal Metastases According to the Margin of the Largest Lesion.
Sasaki K; Margonis GA; Maitani K; Andreatos N; Wang J; Pikoulis E; He J; Wolfgang CL; Weiss M; Pawlik TM
Ann Surg Oncol; 2017 Sep; 24(9):2438-2446. PubMed ID: 28695393
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
Solaini L; Gardini A; Passardi A; Mirarchi MT; D'Acapito F; La Barba G; Cucchi M; Casadei Gardini A; Frassineti GL; Cucchetti A; Ercolani G
Am Surg; 2019 May; 85(5):488-493. PubMed ID: 31126361
[TBL] [Abstract][Full Text] [Related]
13. Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
Berardi G; De Man M; Laurent S; Smeets P; Tomassini F; Ariotti R; Hoorens A; van Dorpe J; Varin O; Geboes K; Troisi RI
Eur J Surg Oncol; 2018 Jul; 44(7):1069-1077. PubMed ID: 29615295
[TBL] [Abstract][Full Text] [Related]
14. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.
Andreou A; Aloia TA; Brouquet A; Dickson PV; Zimmitti G; Maru DM; Kopetz S; Loyer EM; Curley SA; Abdalla EK; Vauthey JN
Ann Surg; 2013 Jun; 257(6):1079-88. PubMed ID: 23426338
[TBL] [Abstract][Full Text] [Related]
15. Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Eur J Surg Oncol; 2015 Jul; 41(7):868-74. PubMed ID: 25865557
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
[TBL] [Abstract][Full Text] [Related]
17. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
Sadot E; Groot Koerkamp B; Leal JN; Shia J; Gonen M; Allen PJ; DeMatteo RP; Kingham TP; Kemeny N; Blumgart LH; Jarnagin WR; DʼAngelica MI
Ann Surg; 2015 Sep; 262(3):476-85; discussion 483-5. PubMed ID: 26258316
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer.
Umehara M; Umehara Y; Takahashi K; Murata A; Nishikawa S; Tokura T; Matsuzaka M; Tanaka R; Morita T
Anticancer Res; 2016 Apr; 36(4):1949-54. PubMed ID: 27069185
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.
Tranchart H; Chirica M; Faron M; Balladur P; Lefevre LB; Svrcek M; de Gramont A; Tiret E; Paye F
World J Surg; 2013 Nov; 37(11):2647-54. PubMed ID: 23982776
[TBL] [Abstract][Full Text] [Related]
20. Interaction of margin status and tumour burden determines survival after resection of colorectal liver metastases: A retrospective cohort study.
Mao R; Zhao JJ; Bi XY; Zhang YF; Li ZY; Zhou JG; Zhao H; Cai JQ
Int J Surg; 2018 May; 53():371-377. PubMed ID: 29229309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
